| MRP2 | Multidrug resistance-associated protein 2 |
|---|---|
| MRPs | Maillard Reaction products |
| MRS | 1)H-magnetic resonance spectroscopy |
| MRS | 31)P-magnetic resonance spectroscopy |
| MRS | MR Spectroscopy |
| MRS | Magnetic resonance imaging and spectroscopy |
| MRS | Mania Rating Scale |
| MRS | Modified Rankin Scale |
| MRSA | Methicilin resistant Staphylococcus Aureus |
| MRSA | Methicillin Resistant |
| MRD |
A standardized method for quantifying the clinical status of a person with MS. The MRD is made up of five parts: demographic information; the Neurological Functional Systems (developed by John Kurtzke), which assign scores to clinical findings for each of the various neurologic systems in the brain and spinal cord (pyramidal, cerebellar, brainstem, sensory, visual, mental, bowel and bladder); the Disability Status Scale (developed by John Kurtzke), which gives a single composite score for ...
출처: www.zdmu.ac.ir/learn/msc/ms03.htm
|
|---|---|
| mrem |
The unit of measure millirem, or thousandth of a rem. See rem.
출처: www.jlab.org/ehs/manual/EHSbook-446.html
|
| mRNA |
A single-stranded molecule of ribonucleic acid that directs protein production.
출처: www.exploratorium.edu/genepool/glossary.html
|
| MRA |
An noninvasive test that uses the injection of dye into the venous system to define the anatomy of the vessels in the body using radio waves and magnetic fields to create a three dimensional image.
출처: www.mctsurgeons.com/glossary.htm
|
| MRL |
An ATSDR estimate of daily human exposure to a hazardous substance at or below which that substance is unlikely to pose a measurable risk of harmful (adverse), noncancerous effects. MRLs are calculated for a route of exposure (inhalation or oral) over a specified time period (acute, intermediate, or chronic). MRLs should not be used as predictors of harmful (adverse) health effects (ATSDR 2003). See reference dose.
출처: www.racteam.com/LANLRisk/Glossary.htm
|